ReP USP - Resultado da busca

Artigo de periodico
Virtual Screening of Adenylate Kinase 3 Inhibitors Employing Pharmacophoric Model, Molecular Docking, and Molecular Dynamics Simulations as Potential Therapeutic Target in Chronic Lymphocytic Leukemia (2021)
Barbosa, Bárbara Lima Fonseca; Freitas, Tulio Resende; Almeida, Michell de Oliveira ; Araújo, Sérgio Schusterschitz da Silva; Andrade, Ana Clara; Dornelas, Geovana Gomes; Fiorotto, Julyana Gayva; Maltarollo, Vinicius Gonçalves; Sabino, Adriano de Paula
Fonte: Future Pharmacology. Unidade: IQSC
Assuntos: LEUCEMIA, ENZIMAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BARBOSA, Bárbara Lima Fonseca et al. Virtual Screening of Adenylate Kinase 3 Inhibitors Employing Pharmacophoric Model, Molecular Docking, and Molecular Dynamics Simulations as Potential Therapeutic Target in Chronic Lymphocytic Leukemia. Future Pharmacology, v. 1, p. 60–79, 2021Tradução . . Disponível em: https://doi.org/10.3390/futurepharmacol1010006. Acesso em: 06 nov. 2024.
APA
Barbosa, B. L. F., Freitas, T. R., Almeida, M. de O., Araújo, S. S. da S., Andrade, A. C., Dornelas, G. G., et al. (2021). Virtual Screening of Adenylate Kinase 3 Inhibitors Employing Pharmacophoric Model, Molecular Docking, and Molecular Dynamics Simulations as Potential Therapeutic Target in Chronic Lymphocytic Leukemia. Future Pharmacology, 1, 60–79. doi:10.3390/futurepharmacol1010006
NLM
Barbosa BLF, Freitas TR, Almeida M de O, Araújo SS da S, Andrade AC, Dornelas GG, Fiorotto JG, Maltarollo VG, Sabino A de P. Virtual Screening of Adenylate Kinase 3 Inhibitors Employing Pharmacophoric Model, Molecular Docking, and Molecular Dynamics Simulations as Potential Therapeutic Target in Chronic Lymphocytic Leukemia [Internet]. Future Pharmacology. 2021 ;1 60–79.[citado 2024 nov. 06 ] Available from: https://doi.org/10.3390/futurepharmacol1010006
Vancouver
Barbosa BLF, Freitas TR, Almeida M de O, Araújo SS da S, Andrade AC, Dornelas GG, Fiorotto JG, Maltarollo VG, Sabino A de P. Virtual Screening of Adenylate Kinase 3 Inhibitors Employing Pharmacophoric Model, Molecular Docking, and Molecular Dynamics Simulations as Potential Therapeutic Target in Chronic Lymphocytic Leukemia [Internet]. Future Pharmacology. 2021 ;1 60–79.[citado 2024 nov. 06 ] Available from: https://doi.org/10.3390/futurepharmacol1010006
Artigo de periodico
A mathematical model for chemoimmunotherapy of chronic lymphocytic leukemia (2019)
Rodrigues, Diego Samuel ; Mancera, Paulo Fernando de Arruda ; Carvalho, Tiago de ; Gonçalves, Luiz Fernando
Fonte: Applied Mathematics and Computation. Unidade: FFCLRP
Assuntos: NEOPLASIAS, QUIMIOTERAPIA, IMUNOTERAPIA, LEUCEMIA, EQUAÇÕES DIFERENCIAIS ORDINÁRIAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
RODRIGUES, Diego Samuel et al. A mathematical model for chemoimmunotherapy of chronic lymphocytic leukemia. Applied Mathematics and Computation, v. 349, p. 118-133, 2019Tradução . . Disponível em: https://doi.org/10.1016/j.amc.2018.12.008. Acesso em: 06 nov. 2024.
APA
Rodrigues, D. S., Mancera, P. F. de A., Carvalho, T. de, & Gonçalves, L. F. (2019). A mathematical model for chemoimmunotherapy of chronic lymphocytic leukemia. Applied Mathematics and Computation, 349, 118-133. doi:10.1016/j.amc.2018.12.008
NLM
Rodrigues DS, Mancera PF de A, Carvalho T de, Gonçalves LF. A mathematical model for chemoimmunotherapy of chronic lymphocytic leukemia [Internet]. Applied Mathematics and Computation. 2019 ; 349 118-133.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1016/j.amc.2018.12.008
Vancouver
Rodrigues DS, Mancera PF de A, Carvalho T de, Gonçalves LF. A mathematical model for chemoimmunotherapy of chronic lymphocytic leukemia [Internet]. Applied Mathematics and Computation. 2019 ; 349 118-133.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1016/j.amc.2018.12.008
Artigo de periodico
Aberrant levels of SUV39H1 and SUV39H2 methyltransferase are associated with genomic instability in chronic lymphocytic leukemia (2017)
Alves‐Silva, Juliana Carvalho; Rabello, Doralina do Amaral; Bravo, Martha Oliveira; Lucena‐Araujo, Antônio; Oliveira, Diego Madureira de; Oliveira, Fábio Morato de; Rego, Eduardo Magalhaes; Pittella‐Silva, Fábio; Saldanha‐Araujo, Felipe
Fonte: Environmental and Molecular Mutagenesis. Unidade: FMRP
Assuntos: LEUCEMIA, CARIOTIPAGEM, ANORMALIDADES CROMOSSÔMICAS, TRANSFERASES, TELÔMERO, IDOSOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ALVES‐SILVA, Juliana Carvalho et al. Aberrant levels of SUV39H1 and SUV39H2 methyltransferase are associated with genomic instability in chronic lymphocytic leukemia. Environmental and Molecular Mutagenesis, v. 58, n. 9, p. 654-661, 2017Tradução . . Disponível em: https://doi.org/10.1002/em.22128. Acesso em: 06 nov. 2024.
APA
Alves‐Silva, J. C., Rabello, D. do A., Bravo, M. O., Lucena‐Araujo, A., Oliveira, D. M. de, Oliveira, F. M. de, et al. (2017). Aberrant levels of SUV39H1 and SUV39H2 methyltransferase are associated with genomic instability in chronic lymphocytic leukemia. Environmental and Molecular Mutagenesis, 58( 9), 654-661. doi:10.1002/em.22128
NLM
Alves‐Silva JC, Rabello D do A, Bravo MO, Lucena‐Araujo A, Oliveira DM de, Oliveira FM de, Rego EM, Pittella‐Silva F, Saldanha‐Araujo F. Aberrant levels of SUV39H1 and SUV39H2 methyltransferase are associated with genomic instability in chronic lymphocytic leukemia [Internet]. Environmental and Molecular Mutagenesis. 2017 ; 58( 9): 654-661.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1002/em.22128
Vancouver
Alves‐Silva JC, Rabello D do A, Bravo MO, Lucena‐Araujo A, Oliveira DM de, Oliveira FM de, Rego EM, Pittella‐Silva F, Saldanha‐Araujo F. Aberrant levels of SUV39H1 and SUV39H2 methyltransferase are associated with genomic instability in chronic lymphocytic leukemia [Internet]. Environmental and Molecular Mutagenesis. 2017 ; 58( 9): 654-661.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1002/em.22128
Artigo de periodico
Telomere length analysis in monoclonal B-cell lymphocytosis and chronic lymphocytic leukemia Binet A (2017)
Furtado, Felipe Magalhães; Scheucher, Priscila Santos; Santana, Bárbara Amélia Aparecida; Scatena, Natália Ferreira; Calado, Rodrigo Tocantins; Rego, Eduardo Magalhães; Matos, Daniel Mazza; Falcão, Roberto Passetto
Fonte: Brazilian Journal of Medical and Biological Research. Unidade: FMRP
Assuntos: LINFÓCITOS B, ESTUDOS DE CASOS E CONTROLES, CITOMETRIA DE FLUXO, LEUCEMIA, TELÔMERO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FURTADO, Felipe Magalhães et al. Telomere length analysis in monoclonal B-cell lymphocytosis and chronic lymphocytic leukemia Binet A. Brazilian Journal of Medical and Biological Research, v. 50, n. 5, 2017Tradução . . Disponível em: https://doi.org/10.1590/1414-431x20176019. Acesso em: 06 nov. 2024.
APA
Furtado, F. M., Scheucher, P. S., Santana, B. A. A., Scatena, N. F., Calado, R. T., Rego, E. M., et al. (2017). Telomere length analysis in monoclonal B-cell lymphocytosis and chronic lymphocytic leukemia Binet A. Brazilian Journal of Medical and Biological Research, 50( 5). doi:10.1590/1414-431x20176019
NLM
Furtado FM, Scheucher PS, Santana BAA, Scatena NF, Calado RT, Rego EM, Matos DM, Falcão RP. Telomere length analysis in monoclonal B-cell lymphocytosis and chronic lymphocytic leukemia Binet A [Internet]. Brazilian Journal of Medical and Biological Research. 2017 ; 50( 5):[citado 2024 nov. 06 ] Available from: https://doi.org/10.1590/1414-431x20176019
Vancouver
Furtado FM, Scheucher PS, Santana BAA, Scatena NF, Calado RT, Rego EM, Matos DM, Falcão RP. Telomere length analysis in monoclonal B-cell lymphocytosis and chronic lymphocytic leukemia Binet A [Internet]. Brazilian Journal of Medical and Biological Research. 2017 ; 50( 5):[citado 2024 nov. 06 ] Available from: https://doi.org/10.1590/1414-431x20176019
Artigo de periodico
Comparison of microRNA expression in high-count monoclonal B-cell lymphocytosis and Binet A chronic lymphocytic leukemia (2017)
Furtado, Felipe Magalhães; Scheucher, Priscila Santos; Santana, Bárbara Amélia Aparecida; Zanette, Dalila Lucíola; Calado, Rodrigo Tocantins; Rego, Eduardo Magalhães; Matos, Daniel Mazza; Falcão, Roberto Passetto
Fonte: Revista Brasileira de Hematologia e Hemoterapia. Unidade: FMRP
Assuntos: LEUCEMIA, MICRORNAS, CITOMETRIA DE FLUXO, REAÇÃO EM CADEIA POR POLIMERASE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FURTADO, Felipe Magalhães et al. Comparison of microRNA expression in high-count monoclonal B-cell lymphocytosis and Binet A chronic lymphocytic leukemia. Revista Brasileira de Hematologia e Hemoterapia, v. 39, n. 3, p. 237-243, 2017Tradução . . Disponível em: https://doi.org/10.1016/j.bjhh.2017.03.006. Acesso em: 06 nov. 2024.
APA
Furtado, F. M., Scheucher, P. S., Santana, B. A. A., Zanette, D. L., Calado, R. T., Rego, E. M., et al. (2017). Comparison of microRNA expression in high-count monoclonal B-cell lymphocytosis and Binet A chronic lymphocytic leukemia. Revista Brasileira de Hematologia e Hemoterapia, 39( 3), 237-243. doi:10.1016/j.bjhh.2017.03.006
NLM
Furtado FM, Scheucher PS, Santana BAA, Zanette DL, Calado RT, Rego EM, Matos DM, Falcão RP. Comparison of microRNA expression in high-count monoclonal B-cell lymphocytosis and Binet A chronic lymphocytic leukemia [Internet]. Revista Brasileira de Hematologia e Hemoterapia. 2017 ; 39( 3): 237-243.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1016/j.bjhh.2017.03.006
Vancouver
Furtado FM, Scheucher PS, Santana BAA, Zanette DL, Calado RT, Rego EM, Matos DM, Falcão RP. Comparison of microRNA expression in high-count monoclonal B-cell lymphocytosis and Binet A chronic lymphocytic leukemia [Internet]. Revista Brasileira de Hematologia e Hemoterapia. 2017 ; 39( 3): 237-243.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1016/j.bjhh.2017.03.006
Artigo de periodico
Residual expression of SMYD2 and SMYD3 is associated with the acquisition of complex karyotype in chronic lymphocytic leukemia (2016)
Oliveira-Santos, Wilson; Rabello, Doralina Amaral; Lucena-Araujo, Antônio Roberto; Oliveira, Fábio Morato de; Rego, Eduardo Magalhães; Silva, Fábio Pittella; Saldanha-Araujo, Felipe
Fonte: Tumor Biology. Unidade: FMRP
Assuntos: BIOMARCADORES, LEUCEMIA, ABERRAÇÕES DOS CROMOSSOMOS SEXUAIS, REGULAÇÃO GÊNICA, ESTADIAMENTO DE NEOPLASIAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
OLIVEIRA-SANTOS, Wilson et al. Residual expression of SMYD2 and SMYD3 is associated with the acquisition of complex karyotype in chronic lymphocytic leukemia. Tumor Biology, v. 37, n. 7, p. 9473-9481, 2016Tradução . . Disponível em: https://doi.org/10.1007/s13277-016-4846-z. Acesso em: 06 nov. 2024.
APA
Oliveira-Santos, W., Rabello, D. A., Lucena-Araujo, A. R., Oliveira, F. M. de, Rego, E. M., Silva, F. P., & Saldanha-Araujo, F. (2016). Residual expression of SMYD2 and SMYD3 is associated with the acquisition of complex karyotype in chronic lymphocytic leukemia. Tumor Biology, 37( 7), 9473-9481. doi:10.1007/s13277-016-4846-z
NLM
Oliveira-Santos W, Rabello DA, Lucena-Araujo AR, Oliveira FM de, Rego EM, Silva FP, Saldanha-Araujo F. Residual expression of SMYD2 and SMYD3 is associated with the acquisition of complex karyotype in chronic lymphocytic leukemia [Internet]. Tumor Biology. 2016 ; 37( 7): 9473-9481.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1007/s13277-016-4846-z
Vancouver
Oliveira-Santos W, Rabello DA, Lucena-Araujo AR, Oliveira FM de, Rego EM, Silva FP, Saldanha-Araujo F. Residual expression of SMYD2 and SMYD3 is associated with the acquisition of complex karyotype in chronic lymphocytic leukemia [Internet]. Tumor Biology. 2016 ; 37( 7): 9473-9481.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1007/s13277-016-4846-z

Unidades USP

ReP

Filtros

Autores

Autores USP

Assuntos

Título da fonte

Agência de fomento

Indexado em

Afiliação dos autores externos não normalizada